The Stanford Daily2d
‘Democratizing biology’: Stanford bioengineering lab provides affordable gene-editing kit for high school students
Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.
pna7h
Gov’t intensifies crackdown on illicit trade, seizes P41-B fake goods
The National Committee on Intellectual Property Rights (NCIPR) has intensified its crackdown on counterfeit goods in the domestic market as seized fake products reached PHP40.99 billion in 2024. The ...
Inquirer on MSN2d
QCPD: Crime in QC district down by 14.12 percent
The Quezon City Police District (QCPD) reported a 14.12-percent drop in major focus crimes, from 701 incidents logged between Oct. 1, 2023, and Feb. 1, 2024, to 602 ...
Korea Joongang Daily on MSN1d
PanGen revenue hits record high as overseas drug orders roll in
PanGen Biotech, a biopharmaceutical subsidiary of Huons Group, reported record-high revenue last year after growth in its biosimilar business took off across the globe. Annual sales were 14.67 billion ...
Inquirer on MSN2d
Nerez appointed new PDEA chief
President Ferdinand “Bongbong” R. Marcos Jr. has named retired Maj. Gen. Isagani Nerez as the new chief of the Philippine ...
BGR6d
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
manilastandard8h
Confiscated fake products up 52% to P41b in 2025
The National Committee on Intellectual Property Rights (NCIPR) said authorities seized counterfeit products valued at P40.99 ...
Today6d
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe ...
Business Insider6d
Biotech Stocks Facing FDA Decision In February 2025
Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...
Business Insider6d
Axsome Therapeutics hosts SYMBRAVO FDA approval investor event
Axsome Therapeutics (AXSM) will host a virtual investor event and conference call at 8:00 AM Eastern Time to discuss the U.S. Food and Drug Administration approval of SYMBRAVO, a novel multi ...
Food Safety News6d
Publisher’s Platform: Senators step up to help save FDA funding of state inspection programs
Democratic senators are expressing alarm about planned budget reallocations at the Food and Drug Administration that they fear will threaten the nation’s food safety system. In a letter to FDA ...
pna12h
First Lady leads Lab for All in Pangasinan town
First Lady Liza Araneta-Marcos led the Lab for All program Thursday here, delivering free medical, dental, and government ...